Close

Global Hunter Securities Reiterates a 'Buy' on Savient Pharmaceuticals (SVNT); Stock Significantly Undervalued

December 1, 2010 9:25 AM EST Send to a Friend
Global Hunter Securities reiterates a 'Buy' rating on Savient Pharmaceuticals (NASDAQ: SVNT), raises PT from $15 to $19.

Global analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login